1. Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation
   Karthik Dhatchinamoorthy et al, 2021, Frontiers in Immunology CrossRef
2. The effect of liver disease on hepatic microenvironment and implications for immune therapy
   Zachary J. Brown et al, 2023, Frontiers in Pharmacology CrossRef
3. Primary and Acquired Resistance against Immune Check Inhibitors in Non-Small Cell Lung Cancer
   Qinying Sun et al, 2022, Cancers CrossRef
4. Differential HLA class I subunit (A, B, C heavy chain and β2-microglobulin) expression levels in normal tissues
   Filippo Ugolini et al, 2023, Virchows Archiv CrossRef
5. Mechanisms of Primary and Acquired Resistance to Immune Checkpoint Inhibitors in Patients with Hepatocellular Carcinoma
   Stefania De Lorenzo et al, 2022, Cancers CrossRef
6. MHC Class I Regulation: The Origin Perspective
   Alicja Sznarkowska et al, 2020, Cancers CrossRef
7. Tumor Microenvironment: Immune Effector and Suppressor Imbalance
   Kelsey Sheehan et al, 2021, Lung Cancer CrossRef
8. NLRC5/MHC class I transactivator: A key target for immune escape by SARS‐CoV‐2
   Baohui Zhu et al, 2024, BioEssays CrossRef
9. Loss of HLA-class-I expression in non-small-cell lung cancer: Association with prognosis and anaerobic metabolism
   Ioannis M. Koukourakis et al, 2022, Cellular Immunology CrossRef